# Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy

> **NCT00517101** · — · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center**

## Conditions studied

- Psoriatic Arthritis
- Ankylosing Spondylitis
- Undifferentiated Spondyloarthropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00517101
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517101, "Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00517101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*